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Background: Much discussion about benign notochordal cell tissue in vertebrae has centered on the nature of its
relationship, if any, to chordoma. Often referred to as benign notochordal cell tumors (BNCTs), these lesions have
unique morphological features, however, differentiating between notochordal cells in discs, BNCT, and chordoma
can be difficult. They are described as radiologically distinct from chordoma, with lysis, contrast enhancement, and
a soft tissue mass indicating chordoma.
Methods: All chordomas diagnosed at our institution, the Istituto Ortopedico Rizzoli (Bologna, Italy), prior to 2008
were reviewed, yielding 174 cases. Five were limited to bone; one was a recurrent chordoma without original data
available. The remaining four were re-evaluated in detail.
Results: There were three women and one man, aged 33–57 years (mean, 48 years). Two were BNCTs and two
were mixed lesions containing BNCT and chordoma. On computed tomography, all were radiopaque with areas of
lysis. One BNCT was heterogeneous on magnetic resonance imaging, enhancing after contrast. Microscopically, one
BNCT had a well-defined cystic area with a sclerotic border. The other had a minute atypical area; it recurred as
chordoma. The mixed lesions had areas of definitive BNCT, definitive chordoma, and atypical areas that did not
meet the criteria for either. The atypical areas in all three cases ‘blended’ with areas of chordoma or BNCT.
Conclusion: These cases illustrate the ongoing challenges in differentiating between BNCT and chordoma. All had
unique imaging features; three had atypical microscopic areas blending with BNCT or chordoma, strengthening the
argument for a relationship between the two entities and supporting the idea that some BNCTs may progress to
chordoma. Our study dispels the notion that any single radiologic criterion used to distinguish between chordoma
and BNCT is reliable, opening the discussion as to whether or how to monitor BNCTs.
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Intraosseous benign-appearing notochordal tissue has
been observed in isolated fetal and adult spines during
the last century [1-3], but only in the last three decades
has it been well-characterized and explored in greater
detail. Contemporary work called on previous studies by
pathologists, anatomists, and embryologists, raising myr-
iad questions about the natural history of the notochord
and the origin of all notochordal lesions. Important case* Correspondence: daniel.vanel@ior.it
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unless otherwise stated.reports and series questioned whether this intraosseous
notochordal tissue represented true notochordal rests or
de novo lesions, whether it was benign or malignant
[4-10]. At each turn, terminology changed, from ecchordo-
sis physalifora vertebralis, to giant notochordal rest, to the
now widely-used benign notochordal cell tumor (BNCT)
[4,6,8,9]. Central to the discussion was the nature of the re-
lationship, if any, between this benign-appearing tissue and
chordoma. Several authors reported cases indicating an as-
sociation between BNCT and chordoma [11-16] as others
highlighted clear radiologic and histopathologic criteria for
distinguishing between them [6-10,16,17].l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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nosed as chordoma in order to better characterize their
radiologic and pathologic characteristics and to better de-
lineate any possible relationship between them. What we
found demonstrates that the differences between BNCT
and chordoma are not as simple as was once thought.
Methods
The work was approved by the Institutional review board
of the Rizzoli Institute. We searched the database at our
institution for all cases of chordoma diagnosed prior to
2008; after 2008 BNCT was a well-known entity to us and
was considered as a separate diagnosis when appropriate.
One hundred seventy-four chordomas were found. Of these,
169 had a soft-tissue mass. Five were limited to bone, one of
which was a recurrent chordoma sent from an outside
institution; detailed information regarding the original
lesion was not available. The remaining four cases were
re-evaluated in detail, including review of the charts,
imaging, and pathology. As all cases were originally diag-
nosed as chordoma, each underwent vertebrectomy and
the entire vertebra had been available for study. Many
patients at this institution come by referral, retaining their
original films and all but one of these patients were diag-
nosed before digital imaging was adopted; as a result, not
all imaging performed was presently available.
Results
There were three women, one man, aged 33–57 years
(mean 48) at time of diagnosis. Re-evaluation yielded the
following diagnoses: two BNCTs and two lesions with
areas of both BNCT and chordoma (Figures 1, 2, 3 and 4).
All four patients had lesions located in the posterior as-
pect of lumbar vertebrae. All lesions were mild-moderately
radiodense (sclerotic) on computed tomography (CT) with
varying patterns and amounts of lysis. Two patients (1 and
4) had radiographs available for evaluation; the lesions were
mildly radiodense. Of the patients who had magnetic reso-
nance imaging (MRI) available for evaluation, one was
heterogeneous on both T1- and T2-weighted sequences
and enhanced with contrast administration (Patient 1).
Patient 4 only had T2-weighted images available for eva-
luation; the lesion demonstrated high signal. All patients
had radiologic signs of intralesional fat.
All four cases had areas that definitively met the patho-
logic criteria for BNCT. Patient 1 had classic features of
BNCT as well as a well-limited cystic area, the inside
border of which had layers of cells consistent with the rest
of the lesion. This cystic portion was well-defined with a
sclerotic border and without microscopic evidence of bone
resorption. The lesion for Patient 2 was composed entirely
of classic BNCT except for a minute atypical area. The
other two cases were composed of distinct areas that
definitively met the criteria for BNCT and for chordoma,as well as atypical areas that did not meet the criteria
for either chordoma or BNCT. For all three lesions, the
atypical areas seemed to "blend" or "flow" to/from the
areas of BNCT and chordoma. None of the cases had
microscopic evidence of extraosseous lesion extension.
Discussion
Although intraosseous notochordal remnants have been
recognized for over a century, interest was limited until
recently. Focused studies as well as research in related
topics such as degenerative disc disease have helped ad-
vance our collective knowledge of these lesions; [18-22]
of utmost clinical importance is any relationship to chor-
doma. If all of these lesions naturally progress to chor-
doma or have the potential to transform into chordoma,
they provide the opportunity to catch a malignancy at a
very early, and small, stage.
Fundamental to any discussion of notochordal cell le-
sions is an understanding of notochord development. In
humans, the notochord is a transient embryonic structure
with critical structural and developmental roles [1,3,19].
After inducing vertebral column formation it disappears,
leaving cellular remnants in the nucleus pulposus. There
is later an apparent loss of notochordal cells such that
they have rarely been reported beyond the first decade of
life [2,3,18-22].
Notochordal remnants are occasionally found in fetal
and adult vertebrae, with some suggesting this may be
a more frequent occurrence than observations suggest
[3,4,7,17,18,20,21]. It has been hypothesized that regres-
sion of the notochord may arrest at any point in develop-
ment, leaving notochordal cells along its course that may
then be subject to hyperplasia [1,3,8,17].
Extraosseous masses of benign vacuolated physaliferous
cells at the base of the skull were identified as noto-
chordal remnants in the mid-nineteenth century. Desig-
nated "ecchordosis physalifora", they were considered
proliferation of ectopic tissue due to aberrant notochordal
development and/or regression [1,3,6,8,17]. Malignant
lesions with a similar morphology came to be called
"chordoma"; believed to be of the same origin, it is a rare,
slow-growing tumor with a poor prognosis, selectively
affecting the axial skeleton [8,17,23].
Reports of intraosseous notochordal tissue were scant
until the first modern histopathologic reports opened a
broader discussion [1-6,8]. Initial questions focused on
whether this tissue was a notochordal rest [4-6,8]. Based
on size alone, these lesions had clearly grown beyond
embryologic proportions; sclerotic trabeculae and the
described permeative nature further implied growth. Some
questioned whether a vestige could grow, stating that pro-
liferation implies neoplasia or malignancy [5,6,8]. How-
ever, notochordal cells in the disc have been observed to
have proliferative potential and ecchordosis physalifora,
Figure 1 Patient 1, a 33 year-old woman. Images demonstrate radiodensity (sclerosis) (radiograph, a) as well as lytic areas (CT, b and c). The
lesion is heterogeneous on both T1- (d and e) and T2-weighted (f) sequences and takes up contrast moderately (g and h). The sclerotic aspect
on imaging corresponds to classic areas of BNCT: permeative sheets of adipocyte-like tumor cells associated with bone sclerosis and mixed with
normal bone marrow islands (i). The round lytic area on imaging (c) corresponds to a centrally emptied notochordal cell lesion without evidence
of chordoma at the periphery of the lesion (j). The cystic nature of this lesion is best seen on T2-weighted imaging (f).
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rest" [3,8,17,21]. Moreover, it was argued that permeation
is not a sine qua non for malignancy; that these lesions
seemed to expand within the confines of the vertebrae
without destruction while exhibiting permeative growth,
some largely unchanged after years, supported the argu-
ment that they are benign [6,8]. Others argued that these
may be characteristics of pre-chordomas or the earlyFigure 2 Patient 2, a 57 year-old woman. CT images reveal a mostly sclero
L4 (a and b). c: Similar lesion in the thoracic spine (discovered retrospectively
component is composed of permeative sheets of cells (H&E, obj. 4, d). e: The
area surrounded by osteosclerosis; higher magnification (g) reveals spindled n
pattern or clear myxoid stroma (H&E, obj 20). This lesion recurred as a classic
with a nodular growth pattern (H&E, obj 10).stages of very slow-growing chordomas [5,6,8]. In ensuing
years, Japanese colleagues made significant contributions;
they proffered that BNCTs were not merely the intraoss-
eous counterparts to notochordal vestiges in discs but
benign, slow-growing lesions which develop after birth,
capable of malignant transformation [7,9-11].
Further questions regarding the origin and natural
history of these lesions arose; did the notochordal cellstic lesion with focal areas of lysis, compromising the posterior cortex of
, not biopsied); fat is visible inside the lesion. Microscopically, the BNCT
cells are adipocyte-like without atypia (H&E, obj 20). f: A minute atypical
otochordal cells with moderate atypia, but without a nodular growth
chordoma (h): cords and strands of tumor cells in a myxoid background
Figure 3 Patient 3, 53 year-old woman. a and b: CT demonstrates a mostly sclerotic lesion with small areas of lysis. c: The main part of the
lesion is a chordoma, revealing the characteristic destructive nodular growth pattern of the tumor (H&E, obj 4). On higher power (d), cords and
strands of tumors cells in an abundant myxoid background with mild atypia are seen (H&E, obj 20). e: a small area of BNCT is composed of sheets of
adipocyte-like cells, without a nodular growth pattern or myxoid background (H&E, obj 20). The atypical areas (f and g) do not fulfill the criteria for
BNCT or chordoma. f: micronodular growth pattern, no myxoid background (H&E, obj 4). Eosinophilic spindle cells with mild atypia (g).
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lack of growth arrest as opposed to an initiation of
growth? Is this true neoplasia or benign hyperplasia? As
more cases came to light, various authors proposed
radiologic and microscopic criteria to help distinguish
BNCTs from chordoma [6-10,16].
Radiology
Chordomas present as destructive, lytic lesions of bone on
radiographs and CT, although intralesional calcification and
varying radiodensity is reported [5,8,14,17,24]. Bony expan-
sion may be seen. Bone scans demonstrate reduced or nor-
mal uptake [6,23]. MRI reveals low-intermediate signal on
T1-weighted and high signal on T2-weighted sequences,
usually with evidence of a large soft tissue mass [16,17,24].Figure 4 Patient 4, 48 year-old male. Radiograph of resected vertebra d
portions of which compromise the posterior cortex (b and c). This area co
atypical tissue transitions between chordoma (left) and BNCT (right) (H&E, o
eosinophilic and vacuolated cells in a myxoid background (H&E, obj 10). g:
cells associated with bone sclerosis (H&E, obj 10).Enhancement is common after contrast administration
[14,16,17,24]. This tumor is slow-growing and progresses
over time [6,8,17,23].
BNCTs of adequate size to be detected radiologically
may or may not demonstrate mild to marked radioden-
sity (usually described as sclerosis) on radiographs and/
or CT; the lesion is confined to the bone without expan-
sion [6,8,10,16,17]. MRI is the most useful modality for
detection. Most studies describe these lesions as low-
intermediate signal intensity on T1-weighted images and
intermediate-high signal intensity on T2-weighted im-
ages, occasionally heterogeneously so, with a lack of en-
hancement with contrast administration; [6,10,16,17,25]
two authors report "poor" and definitive enhancement, re-
spectively [6,11]. Bone scans are usually normal, however,emonstrates a radiodense lesion (a). On CT, areas of lysis are seen,
rresponds to high signal on T2-weighted MRI (d). e: Microscopically,
bj 4). f: The chordomatous component is composed of cords of
The BNCT component consists of permeative sheets of adipocyte-like
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[6,10,17]. Maintenance of trabecular architecture without
bony destruction or expansion, lack of soft tissue exten-
sion, and a lack of enhancement after contrast administra-
tion have been reported as the most reliable means of
distinguishing between BNCTand chordoma radiographic-
ally [8,10,16,17] (Table 1).
Pathology
That the embryonal notochord, notochordal remnants
in the disc, ecchordosis physalifora, BNCT, and chor-
doma have remarkable histopathologic similarity is well-
documented; diagnosis by light microscopy alone is difficult
[1,3,6,8,22]. All contain univacuolated physaliferous cells
and have similar immunohistochemical patterns, staining
for S100, vimentin, EMA, and low-molecular weight cyto-
keratin and are negative for high-molecular weight cyto-
keratin [3,6-8,10,17]. Although cytokeratin 18 expression is
now considered unreliable for differentiating between these
lesions, brachyury, a transcription factor important in no-
tochordal development, has been found to be a consistent
marker for notochordal cell lesions [14,17,21,22,26].
Benign notochordal cell tumors are well-delineated le-
sions consisting of sheets or nests of physaliferous cells.
These cells replace the bone marrow, filling the medullary
spaces between bony trabeculae, but trabecular architec-
ture is preserved. Hematopoietic islands or islands of mar-
row fat may be seen between the sheets of cells [6,9,10,17].
Trabeculae often demonstrate thickening, cement lines,
and appositional or reactive new bone formation, correla-
ting with the radiodensity often seen on CT and radio-
graphs [5-9]. At low power, these cells may be confused
with fat [6,10,14]. At high magnification, the characteristic
physaliferous cells have a clear cytoplasm and eccentrically
located oval or round nuclei. Also seen are less vacuolated
cells with central, rounded nuclei and eosinophilic cyto-
plasm. Nuclear atypia is minimal; pleomorphism, mitoses,
and necrosis are not seen [6,17]. Microcystic spaces with
colloid-like material have been observed in some lesions
[9,10]. Two of the key features differentiating these lesions
are that they are not lobulated and lack a myxoid back-
ground [6]. Although soft tissue extension has not beenTable 1 Differences between BNCT and chordoma
on imaging
BNCT Chordoma
Radiographs and CT Sclerosis. Conservation
of bone trabeculae
Lysis.
MR signal Dark on T1, white on T2 Dark on T1, white on T2
MR after contrast
medium injection
No change Strong uptake
Cortex Normal Destroyed
Soft tissues Normal Invadedreported radiologically, this lesion has been reported to
extend extraosseously on microscopic examination [9,27].
Chordomas are characterized by a destructive growth
pattern. Fibrous septae separate the lesion into lobules,
within which are cords and strands of epithelial-like cells
with clear, vacuolated cytoplasm (the physaliferous cells)
or granular, eosinophilic cytoplasm, all set in a myxoid
matrix. Atypia, pleomorphism, and mitotic figures may
be mild or marked; necrosis may be seen and bony
destruction is evident. Bone marrow and fat may be seen
at the edge of the lesion but not within it. Chordomas
exhibit a significant amount of histopathological variation
from field to field, such that not all diagnostic features
may be seen in a small specimen [6,8,17].
Relationship between BNCT and chordoma
It has long been thought that chordomas might arise
from notochordal remnants [1-4,8,17], with early argu-
ments centered on their similar anatomical distributions
[4,6,7,10,13,17,28]. As precursors, one would expect the
incidence of rests to be higher than that of chordomas;
chordomas occur at a rate of 0.08 per 100,000 while the
incidence of BNCT has been reported as high as 20%
[7,28], suggesting that if they are the precursors to chor-
doma, not all will transform.
Reports of BNCT and chordoma in the same person
and even the same vertebra prompted several authors to
propose that the chordomas had developed from the
BNCT [1,11,13-16]. These authors described at minimum
a sharp interface between, if not distinct separation of, the
chordomatous and BNCT tissues, leading one group of
authors to acknowledge that they could not rule out the
possibility that the rare chordoma had arisen coinciden-
tally with the more common BNCT [12].
Yamaguchi et al. detailed more compelling cases of
microscopic foci of BNCT and chordoma in the same
vertebrae of two elderly patients [12]. Referred to as
"incipient chordomas" due to their size and because, al-
though "occasionally arranged in a small lobular config-
uration", some classic aspects of chordoma were lacking,
they concluded that the BNCT tissue had transformed.
Certainly, these findings are very interesting. Both pa-
tients died of carcinoma; it is unclear if they had
received chemotherapy, which another author suggested
could cause morphological degeneration of notochordal
remnants, possibly causing confusion [17]. Consistent
with previous studies, the authors reported a sharp
interface between the two tissue types.
Unique features of our cases
Two of our cases were intraosseous chordomas without
a soft tissue component (Patients 3, 4); these cases also
had distinct areas of BNCT, as well as atypical tissue that
failed to meet criteria for either BNCT or chordoma but
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A third case was composed almost entirely of BNCT
tissue with a very small atypical area (Figure 2f-g); this
recurred as chordoma, despite an original vertebrectomy
(Figure 2h). In each of these cases, there was "blending"
or "flow" between the tissue types, without any sharp
interfaces or clear demarcation to distinguish them
(Figure 4e). Only one case failed to show any atypical
areas or malignancy (Patient 1). It was distinctive for
its macrocystic component, which had a well-defined
sclerotic border, and for lack of any microscopic bone
resorption, features consistent with a benign lesion
(Figure 1).
These cases illustrate several important points. While
the microscopic criteria for BNCT are well-described,
the lines for the radiologic criteria seem to be ever more
blurred. Several authors suggested that a key distingui-
shing feature of chordoma is the presence of a soft tissue
mass; [10,16,17] on this basis, it seemed likely that all
four of these intraosseous lesions initially diagnosed as
chordoma would be BNCT. On the contrary, two of the
four lesions had distinct chordomatous components.
These findings demonstrate what makes sense intui-
tively: that very early stage chordomas will not demon-
strate macroscopic - or any - soft tissue masses [5,8].
Likewise, a lack of contrast enhancement has been sug-
gested as one of the primary means of differentiation
between the two lesions [16]. However, chordomas and
BNCTs have been reported to exhibit varying degrees of
enhancement [6,11,24] and our case of BNCT demon-
strated moderate enhancement (Figure 1g-h).
It has generally been accepted that lysis or evidence of
bony destruction on imaging is inconsistent with a diag-
nosis of BNCT [8,10,16]. An interesting recent report of
a BNCT demonstrated "bubbly" low-density areas with
intact trabeculae surrounded by sclerosis on CT that
corresponded to foci of increased signal on T1-weighted
images [29]. These created a heterogeneous appearance
on MRI and, after re-review of the authors' previous case
with macrosection, were concluded to represent marrow
inclusions. Although some authors previously reported
heterogeneous MRI signal patterns for BNCT [14,25]
and others appear to have similar findings [6,8,10], this
was the first study to correlate imaging with a well-
known microscopic characteristic of BNCT.
Similar findings were revealed in our cases; three had
lesions with a comparable appearance: lucent areas
with intact trabeculae, surrounded by sclerosis on CT
(Figures 1c, 2a-c, 3a-b, 4b-c). Patient 1 also demon-
strated the aforementioned heterogeneity and pattern on
MRI (Figure 1d-f ). However, the lytic macrocystic area
seen on CT (Figure 1b) was only clearly evident on MRI
on T2-weighted sequences (Figure 1f ), and therefore did
not represent marrow. It was difficult to appreciate onT1-weighted imaging (Figure 1d-e) and did not enhance
with contrast (Figure 1g-h), indicating it might have been
thick fluid. Certainly, it could be argued that perhaps the
center of this lesion contained necrosis or myxoid ma-
terial, possibly representing the beginnings of chordoma.
As the cystic area was centrally empty on slides, it is
impossible to be sure, however, the cells lining the cavity
were BNCT without atypical areas or chordoma. In
addition, its sclerotic border (Figure 1b, i) and the overall
appearance of the lesion were consistent with the benign
pathologic findings (Figure 1i-j).
More unique features were demonstrated in two of
our cases with larger areas of lysis with compromise of
trabecular architecture and destruction of the posterior
cortex (Figures 2a-b, 4b-c). While this is not entirely
surprising considering the microscopic evidence for
chordoma in Patient 4, the lysis is fairly pronounced for
Patient 2 considering mostly BNCT with only a minute
focus of atypical tissue was found.
Portions of all four cases had the appearance of intra-
lesional fat on CT (Figures 1c, 2a-c, 3a-b, 4b-c) and MRI
(Figure 1e-f ), a finding usually highly suggestive of a
benign lesion [30]. Yet, two of these four cases had evi-
dence of chordoma; one had lysis adjacent to the more
benign-appearing area (Figure 4b-c), reflective of the
pathology. Patient 3, however, had radiologic findings
comparable with the aforementioned study [29], despite
the main part of the lesion being chordoma.
Importantly, these cases underscore the significant dif-
ficulty in differentiating between BNCT and chordoma
and the very real risk of misdiagnosis not only radio-
logically, but also histopathologically. Microscopic diag-
nosis is dependent on the proper specimen, made all the
more challenging by the usual sampling technique and
size for these lesions (needle biopsy through the pedicle)
and by the microscopic heterogeneity of chordoma
[6,8,17]. Patient 2 illustrates just how easily the diagnosis
of chordoma can be missed; the atypical area was insuffi-
cient to meet the criteria for chordoma (Figure 2f-g).
Moreover, this area was an extremely small portion of
the overall sample, easily able to be missed. Was this a
sampling error of a lesion that was already a chordoma
or was this the most "malignant" portion of the lesion
on gross examination, appropriately sampled and eva-
luated, and it was only over time that it transformed into
chordoma?
These atypical areas may be sites of active malignant
transformation or precursor, transitional tissue. It is
possible that there are variants of BNCT, some already
early chordomas or predetermined to become chor-
doma, others destined to remain benign. Or perhaps,
given the rarity of chordomas relative to BNCTs, all
BNCTs have the potential to transform into chordoma
under the right circumstances, such as an environmental
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implicated gene amplification and duplication in chor-
doma development, with attention focused on Sonic
hedgehog and T (brachyury) genes [15,20,21,23,26]. That
chordomas are rare before mid-life but benign noto-
chordal tissue has been found in vertebrae at all ages
further supports this hypothesis [3,4,8-10,23,25,28].
Morphology is confusing; fetal notochordal tissue has
cords and nests in a myxoid background like chordoma,
however, BNCT lacks these features. These differences
may be explained by different local environments such as
bone marrow, which may promote proliferation, possibly
because of pressure or vascularity differences, growth
factors, or some combination thereof or, perhaps, as
some authors contend, these lesions arise de novo as
notochordal-type tissue expressing markers like brachyury
[10,21,22,25]. Similarly, it has been suggested that the
widespread belief that chordomas are of notochordal
origin may be incorrect [17], that they may originate from
another cell type, expressing genes and proteins consistent
with notochordal cells. However, a recent fate-mapping
study in mice demonstrated notochordal remnants in the
vertebrae or, rarely, the annulus fibrosis; they were found
along the entire vertebral column, were seen in all animals
studied, and remained throughout life [20]. If a similar
process takes place in humans and these remnants remain
dormant for years, then the transitional atypical tissue
seen in our study is likely benign to malignant transfor-
mation in progress.
It is our opinion that BNCTs are notochordal rem-
nants that have the potential for malignant transfor-
mation. They may grow with the vertebrae, occasionally
becoming quite large, but retaining their benign charac-
teristics. That several cases have not changed substan-
tially over years, coupled with the high incidence of
BNCTs relative to chordomas, Horwitz' comprehensive
work, and the aforementioned lineage study underscore
their benign nature [3,6,8,10,17,20].
Investigations over the last three decades have shed
significant light on these intraosseous foci of notochordal
tissue. While there remains much to be elucidated, our
cases strengthen the argument for a relationship between
BNCT and chordoma; the BNCT that recurred as a chor-
doma is certainly provoking, but not yet sufficient to state
it was a purely benign-to-malignant transformation. It is
encouraging to think that chordoma may be caught in its
earliest stages, thus reducing morbidity for the patient. If
BNCT is found more frequently than one in five patients,
as some suspect [7,13,20], this poses an important ques-
tion for clinicians: are all BNCT to be followed routinely?
If yes, over what intervals and for how long? At present
no one radiologic aspect confirms a diagnosis. It is change
of the lesion over time that appears to be the most helpful
radiologic sign, with the development of bony destruction,lysis, enhancement with contrast, and/or a soft tissue mass
to be the most worrisome indication of chordoma. Above
all, close correlation between radiologic and histopatho-
logic findings is critical.
Conclusion
We present four cases that illustrate ongoing challenges
in the diagnostic differentiation between BNCT and
chordoma. All of the cases had unique features on im-
aging and three had atypical areas on histopathology.
While we maintain that BNCT is itself a benign entity,
the microscopic blending of these atypical areas with
BNCT and/or chordoma strengthens the argument for a
relationship between the two entities and supports the
idea that some BNCT may progress to chordoma. Our
study highlights the need for adequate imaging and sam-
pling and close correlation between radiology and histo-
pathology. It dispels the notion that any single radiologic
criterion to distinguish between BNCT and chordoma is
reliable and opens the discussion as to whether or how
to monitor BNCTs.
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